awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43060768-280AF1EA-77A1-4E45-B7A2-1360636B96BF
Q43060768-280AF1EA-77A1-4E45-B7A2-1360636B96BF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43060768-280AF1EA-77A1-4E45-B7A2-1360636B96BF
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.
P2860
Q43060768-280AF1EA-77A1-4E45-B7A2-1360636B96BF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43060768-280AF1EA-77A1-4E45-B7A2-1360636B96BF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39ba61a6edeafe2415b07c2b4391dc1ac95c6ece
P2860
Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908.